Point Of Care Hematology Diagnostics Global Market Report 2025

Description

Point-of-care hematology diagnostics refer to medical tests conducted at or near the site of patient care to quickly evaluate blood-related conditions, such as anemia, infections, or clotting disorders. These tests deliver rapid and accurate hematological results to support timely clinical decisions, particularly in emergency or resource-limited settings. This approach minimizes the reliance on centralized laboratory testing and accelerates diagnosis and treatment.

The primary types of point-of-care hematology diagnostics include complete blood count (CBC), coagulation testing, hemoglobin testing, anemia diagnosis, and others. A CBC measures various blood components, including red blood cells, white blood cells, hemoglobin, hematocrit, and platelets, helping to assess overall health and detect a wide range of disorders. These diagnostics are available as consumables and systems and are offered in both prescription-based and over-the-counter formats, serving end users such as diagnostic centers, hospitals, blood banks, transfusion centers, and other healthcare facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The point-of-care hematology diagnostics market research report is one of a series of new reports from The Business Research Company that provides point-of-care hematology diagnostics market statistics, including point-of-care hematology diagnostics industry global market size, regional shares, competitors with a point-of-care hematology diagnostics market share, detailed point-of-care hematology diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the point-of-care hematology diagnostics industry. This point-of-care hematology diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The point of care hematology diagnostics market size has grown strongly in recent years. It will grow from $2.66 billion in 2024 to $2.90 billion in 2025 at a compound annual growth rate (CAGR) of 9.1%. The growth during the historic period can be attributed to the increasing prevalence of hematological disorders, the expansion of decentralized healthcare settings, growing focus on early disease detection, rising healthcare expenditures in emerging markets, and the growing adoption of portable diagnostic devices.

The point of care hematology diagnostics market size is expected to see strong growth in the next few years. It will grow to $4.05 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. The growth during the forecast period can be attributed to the increasing adoption of personalized medicine, rising demand for immediate clinical decision-making, growing use of home healthcare diagnostics, higher prevalence of blood-related disorders, and heightened awareness of preventive healthcare. Key trends expected during the forecast period include advanced connectivity features in hematology analyzers, innovations in sample preparation methods, integration of artificial intelligence in diagnostic tools, developments in single-cell analysis, adoption of cloud-based data platforms, and advancements in lab-on-a-chip solutions.

The increasing prevalence of blood disorders is expected to drive significant growth in the point-of-care hematology diagnostics market. Blood disorders are the conditions affecting red blood cells, white blood cells, platelets, or plasma are rising largely due to the growing incidence of chronic diseases, which directly impact blood health and necessitate regular monitoring. Point-of-care hematology diagnostics facilitate timely detection and management of these disorders by providing rapid, accurate results at or near the patient care site, enabling faster clinical decisions and improved disease management. For example, in April 2024, the Perth Blood Institute, an Australia-based non-profit, reported that the number of individuals diagnosed with hemophilia increased to 257,146 in 2022, up from 233,577 in 2021. This trend underscores the critical role of point-of-care hematology diagnostics in addressing the rising incidence of blood disorders.

Key companies in this market are developing advanced solutions, such as cartridge-based AI-powered hematology analyzers, to deliver rapid and precise on-site blood analysis. These compact devices utilize single-use reagent cartridges and artificial intelligence algorithms to perform complete blood counts (CBC) and other analyses directly at the point of care. For instance, in September 2024, Zoetis Inc., a US-based veterinary health company, launched Vetscan OptiCell, a cartridge-based, AI-powered hematology analyzer for veterinary use. This system provides rapid, reference-quality CBC results within minutes, while minimizing maintenance and hands-on time. It features AI-driven image analysis and viscoelastic focusing technology to accurately align cells, classify blood cells, and automatically detect abnormalities, ensuring reliable and efficient diagnostics.

In June 2023, Mars Inc., a US-based pet company, acquired Heska Corporation for an undisclosed amount. This acquisition expands Mars' veterinary diagnostics capabilities and strengthens its position in advanced animal healthcare by leveraging Heska's point-of-care hematology and specialty diagnostic solutions.

Major players in the point of care hematology diagnostics market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Sysmex Corporation, HORIBA Ltd., Nova Biomedical Corp., S.D. Sight Diagnostics Ltd., EKF Diagnostics Holdings plc., Medsource Ozone Biomedicals Pvt. Ltd., BioSystems S.A., Chengdu Seamaty Technology Co. Ltd., Drucker Diagnostics LLC, Diamond Diagnostics Inc., DIAGON Kft., BioMedomics Inc., Norma Instruments Zrt., PixCell Medical Technologies Ltd.

North America was the largest region in the point of care hematology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in point of care hematology diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the point of care hematology diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The point of care hematology diagnostics market consists of revenues earned by entities by providing services such as rapid blood testing, decentralized diagnostic solutions, and home-based blood monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The point of care hematology diagnostics market also includes sales of portable hematology analyzers, cartridges and test kits, lancets, and reagents. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Point Of Care Hematology Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on point of care hematology diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for point of care hematology diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The point of care hematology diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Complete Blood Count; Coagulation Testing; Hemoglobin Testing; Anemia Diagnosis; Other Types
2) By Product: Consumables; Systems
3) By Mode Of Prescription: Prescription Based Product; Over-The-Counter Based Product
4) By End User: Diagnostic Centers; Hospitals; Blood Banks; Transfusion Centers; Other End Users
Subsegments:
1) By Complete Blood Count: White Blood Cell Count; Red Blood Cell Count; Platelet Count; Hematocrit; Hemoglobin Concentration; Mean Corpuscular Volume (MCV)
2) By Coagulation Testing: Prothrombin Time (PT); Activated Partial Thromboplastin Time (aPTT); International Normalized Ratio (INR); D-Dimer Test; Fibrinogen Level
3) By Hemoglobin Testing: Total Hemoglobin; Glycated Hemoglobin (HbA1c); Oxyhemoglobin; Carboxyhemoglobin; Methemoglobin
4) By Anemia Diagnosis: Iron Studies; Vitamin B12 Levels; Folate Levels; Reticulocyte Count; Ferritin Test; Transferrin Saturation
5) By Other Types: Blood Typing And Crossmatching; Erythrocyte Sedimentation Rate; Malaria Parasite Detection; Sickle Cell Screening; C-Reactive Protein Testing
Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers AG; Shenzhen Mindray Bio-Medical Electronics Co. Ltd.; Sysmex Corporation; HORIBA Ltd.; Nova Biomedical Corp.; S.D. Sight Diagnostics Ltd.; EKF Diagnostics Holdings plc.; Medsource Ozone Biomedicals Pvt. Ltd.; BioSystems S.A.; Chengdu Seamaty Technology Co. Ltd.; Drucker Diagnostics LLC; Diamond Diagnostics Inc.; DIAGON Kft.; BioMedomics Inc.; Norma Instruments Zrt.; PixCell Medical Technologies Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r37859

1. Executive Summary

2. Point Of Care Hematology Diagnostics Market Characteristics

3. Point Of Care Hematology Diagnostics Market Trends And Strategies

4. Point Of Care Hematology Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Point Of Care Hematology Diagnostics Growth Analysis And Strategic Analysis Framework

5.1. Global Point Of Care Hematology Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Point Of Care Hematology Diagnostics Market Growth Rate Analysis
5.4. Global Point Of Care Hematology Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Point Of Care Hematology Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Point Of Care Hematology Diagnostics Total Addressable Market (TAM)

6. Point Of Care Hematology Diagnostics Market Segmentation

6.1. Global Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Complete Blood Count
Coagulation Testing
Hemoglobin Testing
Anemia Diagnosis
Other Types
6.2. Global Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Consumables
Systems
6.3. Global Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Prescription Based Product
Over-The-Counter Based Product
6.4. Global Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Diagnostic Centers
Hospitals
Blood Banks
Transfusion Centers
Other End Users
6.5. Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Complete Blood Count, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
White Blood Cell Count
Red Blood Cell Count
Platelet Count
Hematocrit
Hemoglobin Concentration
Mean Corpuscular Volume (MCV)
6.6. Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Coagulation Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Prothrombin Time (PT)
Activated Partial Thromboplastin Time (aPTT)
International Normalized Ratio (INR)
D-Dimer Test
Fibrinogen Level
6.7. Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Hemoglobin Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Total Hemoglobin
Glycated Hemoglobin (HbA1c)
Oxyhemoglobin
Carboxyhemoglobin
Methemoglobin
6.8. Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Anemia Diagnosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Iron Studies
Vitamin B12 Levels
Folate Levels
Reticulocyte Count
Ferritin Test
Transferrin Saturation
6.9. Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Blood Typing And Crossmatching
Erythrocyte Sedimentation Rate
Malaria Parasite Detection
Sickle Cell Screening
C-reactive Protein Testing

7. Point Of Care Hematology Diagnostics Market Regional And Country Analysis

7.1. Global Point Of Care Hematology Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Point Of Care Hematology Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Point Of Care Hematology Diagnostics Market

8.1. Asia-Pacific Point Of Care Hematology Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Point Of Care Hematology Diagnostics Market

9.1. China Point Of Care Hematology Diagnostics Market Overview
9.2. China Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Point Of Care Hematology Diagnostics Market

10.1. India Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Point Of Care Hematology Diagnostics Market

11.1. Japan Point Of Care Hematology Diagnostics Market Overview
11.2. Japan Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Point Of Care Hematology Diagnostics Market

12.1. Australia Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Point Of Care Hematology Diagnostics Market

13.1. Indonesia Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Point Of Care Hematology Diagnostics Market

14.1. South Korea Point Of Care Hematology Diagnostics Market Overview
14.2. South Korea Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Point Of Care Hematology Diagnostics Market

15.1. Western Europe Point Of Care Hematology Diagnostics Market Overview
15.2. Western Europe Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Point Of Care Hematology Diagnostics Market

16.1. UK Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Point Of Care Hematology Diagnostics Market

17.1. Germany Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Point Of Care Hematology Diagnostics Market

18.1. France Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Point Of Care Hematology Diagnostics Market

19.1. Italy Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Point Of Care Hematology Diagnostics Market

20.1. Spain Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Point Of Care Hematology Diagnostics Market

21.1. Eastern Europe Point Of Care Hematology Diagnostics Market Overview
21.2. Eastern Europe Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Point Of Care Hematology Diagnostics Market

22.1. Russia Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Point Of Care Hematology Diagnostics Market

23.1. North America Point Of Care Hematology Diagnostics Market Overview
23.2. North America Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Point Of Care Hematology Diagnostics Market

24.1. USA Point Of Care Hematology Diagnostics Market Overview
24.2. USA Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Point Of Care Hematology Diagnostics Market

25.1. Canada Point Of Care Hematology Diagnostics Market Overview
25.2. Canada Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Point Of Care Hematology Diagnostics Market

26.1. South America Point Of Care Hematology Diagnostics Market Overview
26.2. South America Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Point Of Care Hematology Diagnostics Market

27.1. Brazil Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Point Of Care Hematology Diagnostics Market

28.1. Middle East Point Of Care Hematology Diagnostics Market Overview
28.2. Middle East Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Point Of Care Hematology Diagnostics Market

29.1. Africa Point Of Care Hematology Diagnostics Market Overview
29.2. Africa Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Point Of Care Hematology Diagnostics Market Competitive Landscape And Company Profiles

30.1. Point Of Care Hematology Diagnostics Market Competitive Landscape
30.2. Point Of Care Hematology Diagnostics Market Company Profiles
- 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

31. Point Of Care Hematology Diagnostics Market Other Major And Innovative Companies

31.1. Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
31.2. Sysmex Corporation
31.3. HORIBA Ltd.
31.4. Nova Biomedical Corp.
31.5. S.D. Sight Diagnostics Ltd.
31.6. EKF Diagnostics Holdings plc.
31.7. Medsource Ozone Biomedicals Pvt. Ltd.
31.8. BioSystems S.A.
31.9. Chengdu Seamaty Technology Co. Ltd.
31.10. Drucker Diagnostics LLC
31.11. Diamond Diagnostics Inc.
31.12. DIAGON Kft.
31.13. BioMedomics Inc.
31.14. Norma Instruments Zrt.
31.15. PixCell Medical Technologies Ltd.

32. Global Point Of Care Hematology Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Point Of Care Hematology Diagnostics Market

34. Recent Developments In The Point Of Care Hematology Diagnostics Market

35. Point Of Care Hematology Diagnostics Market High Potential Countries, Segments and Strategies

35.1 Point Of Care Hematology Diagnostics Market In 2029 - Countries Offering Most New Opportunities
35.2 Point Of Care Hematology Diagnostics Market In 2029 - Segments Offering Most New Opportunities
35.3 Point Of Care Hematology Diagnostics Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer